cell-and-gene-therapy-rewriting-the-future-of-medicine-365801-960x540
FAQ's
Answer : According to Precedence Research, the global cancer therapeutics market size was valued at US$ 166.5 billion in 2021 and is expected to reach over US$ 365.99 billion by 2030.
Answer : The global cancer therapeutics market is growing at a CAGR of 9.1% over the forecast period 2022 to 2030.
Answer : The major players operating in the cancer therapeutics market are F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, AbbVie, Inc., Johnson & Johnson, Celgene Corporation, AstellasPharma, Inc., Pfizer, Inc., Novartis AG, Merck KGaA, and Eli Lilly and Company.
Answer : The global cancer therapeutics market is propelled by numerous factors such asincrease in cancer prevalence,surge in focus of vendors on the emerging markets,rise in cancer research and surge in collaboration between pharmaceutical companies.
Answer : North America comprise of a market share of more than 35% in 2020 and will lead the global cancer therapeutics market in near future.